Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
COPD, FDA and Dupilumab
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler therapy, according to a press release from manufacturer Regeneron.
Dupixent Approved as Add-On Maintenance Therapy in COPD
The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.
FDA Approves Dupilumab as First Biologic Treatment for COPD
The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly help reduce exacerbations and improve lung function.
emjreviews.com
22h
Sanofi and Regeneron’s allergy drug approved as first biologic for COPD
Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...
Medpage Today on MSN
13d
First Drug OK'd for Chronic Rhinosinusitis With Nasal Polyps in Adolescents
The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Dockworkers launch strike
Medical records breached
Helene wreaks havoc
Kentucky sheriff steps down
Tony-winning star dies
Explosive devices found
Settlement checks delayed
Jimmy Carter turns 100
Wausau drop box replaced
To lay off 2,900 employees
TX fraud probe shut down
OH National Guard to assist
Lose 'superhero' trademark
GA abortion ban blocked
CA bans legacy admissions
'Sing Sing' actor exonerated
How to watch VP debate
Hand count rule challenged
Asylum restrictions extended
Signals more rate cuts
Israel announces operation
NBA Hall of Famer dies
More troops to Middle East
FCC probing outage
Japan's new prime minister
Pete Rose dies at 83
Settles data breach cases
SpaceX Falcon 9 grounded
Related topics
COPD
China
United States
Food and Drug Administration
Regeneron
Feedback